Market coverage note: This article draws on sources from both Korea and the United States. Each piece of information is labeled 🇰🇷 Korea or 🇺🇸 U.S. in the text to indicate which country it applies to.
As the air grows colder, family caregivers feel a familiar chill of worry. When news of a flu outbreak begins to surface in late autumn, the first thought is often, "Did Mom or Dad get their shot this year?" Older adults' respiratory systems are far more vulnerable than those of younger people, due to immune aging. Even when infected with the same virus, they are more likely to develop severe illness, and a single infection can set off a chain of complications. As the seasons change, there has never been a better time to review your loved one's vaccination status.
Influenza is one of the most familiar yet most underestimated infectious diseases for older adults. 🇰🇷 Korea According to the 2024–2025 season National Influenza Annual Report jointly published by the Korea Disease Control and Prevention Agency (질병관리청) and the National Health Insurance Service (국민건강보험공단), influenza vaccination is estimated to have prevented approximately 143,868 inpatient and outpatient cases and 3,506 deaths. The vaccine's effectiveness in preventing severe illness was analyzed at 63.7–74.6%, and its effectiveness in preventing death at 38.1–81.1%. A single vaccine can make that great a difference. 🇰🇷 Korea Adults aged 65 and older can receive the influenza vaccine free of charge at nearby medical institutions starting in October each year, and co-administration with a COVID-19 vaccine on the same day is also recommended. 🇺🇸 U.S. According to CDC data, the 2024–2025 season flu vaccine is estimated to have prevented approximately 240,000 hospitalizations, primarily among adults aged 65 and older.
Pneumonia may be less top-of-mind than the flu, but it poses an even more direct threat to older adults. 🇰🇷 Korea According to Statistics Korea's (통계청) 2024 Cause of Death Statistics, pneumonia ranks as the 2nd leading cause of death among those aged 65 and older in Korea, and rises to the 1st leading cause of death among those aged 80 and older. 90% of pneumonia deaths occur among those aged 65 and older. 🇰🇷 Korea Since 2013, the Korea Disease Control and Prevention Agency (질병관리청) has been running a National Immunization Program offering a single free dose of the pneumococcal vaccine (PPSV23) to adults aged 65 and older. However, as of 2024, the pneumococcal vaccination rate among those aged 65 and older stands at only 55%. 🇺🇸 U.S. According to the CDC National Health Interview Survey (2024), 64.7% of U.S. adults aged 65 and older have received at least one pneumonia vaccine — a decline from 67.0% in 2019.
A third infectious disease has been drawing increasing attention: RSV, or respiratory syncytial virus. 🇰🇷 Korea RSV circulates intensively from October through March of the following year, and in late December 2024 it reached its peak, accounting for 20–30% of all respiratory infections. Domestic research found that approximately 65% of RSV-hospitalized patients were aged 65 and older, and pneumonia was confirmed in 4 out of every 10 patients hospitalized with RSV. There are also reports that 47.9% of adults aged 60 and older who contract RSV experience at least one complication. 🇺🇸 U.S. In the United States, RSV is estimated to cause approximately 110,000–180,000 hospitalizations each year among adults aged 50 and older. Starting in June 2025, the CDC recommends a single dose of the RSV vaccine for high-risk individuals aged 50–59 and for all adults aged 60 and older.
The idea of receiving three vaccines at once may feel overwhelming. However, each vaccine serves a distinct purpose, and in most cases all of them can be given on the same day. 🇰🇷 Korea The Korea Disease Control and Prevention Agency's (질병관리청) immunization guidelines state that the pneumococcal vaccine and the influenza vaccine may be administered on the same day. Because it takes approximately 2 weeks after vaccination for antibodies to form, it is best to complete vaccination by the end of October, before the season peaks. If your parents have already received the pneumococcal vaccine, be sure to check when they received it and which type it was. If it was given before age 65, or if they have a weakened immune system, a booster dose is recommended 5 years later.
The most common reason people delay vaccination is the thought, "They look healthy, so they should be fine." But immune aging in older adults is not always visible on the surface. When underlying conditions such as diabetes, heart disease, or chronic lung disease are compounded by pneumonia or RSV infection, the illness can deteriorate rapidly into severe disease. There are also reports that pneumonia accompanies influenza in 1 out of every 3 adults aged 65 and older who contract the flu. There is no treatment for RSV, making prevention essentially the only line of defense. Regardless of whether underlying conditions are present, age itself is already a high-risk factor.
As a family caregiver, the most practical first step is to check vaccination records. 🇰🇷 Korea You can look up your parents' vaccination history on the 예방접종도우미 (Immunization Helper) website (https://nip.kdca.go.kr). 🇺🇸 U.S. For families living in the United States, vaccination records can be checked through VaxView or at a primary care clinic. Medicare Part B covers most costs for flu, pneumococcal, and COVID-19 vaccines. The RSV vaccine may be covered through Medicare Part D or certain Medicare Advantage plans, so it is a good idea to check your enrolled plan in advance.
Sources: 2024–2025 season National Influenza Annual Report jointly published by the Korea Disease Control and Prevention Agency (질병관리청) and the National Health Insurance Service (국민건강보험공단) (as reported by 팜뉴스 in 2026); Statistics Korea (통계청) 2024 Cause of Death Statistics (as reported by 경향시니어 and 서울경제); Korean Society of Infectious Diseases (대한감염학회) 2024 Vaccination Recommendations (as reported by 경향시니어); 시사저널 RSV feature report (2025); 세계일보 RSV report (2025); 헬스경향 RSV report (2025); U.S. CDC NCHS Data Brief – Vaccinations Among Adults Age 65 and Older: United States, 2024; U.S. CDC 2025–2026 Respiratory Disease Season Outlook; American Lung Association RSV for Healthcare Providers; NFID 2025 National Survey on Respiratory Diseases.
Note: This article was compiled by AI from the sources cited above. We strive for accuracy, but for decisions about your specific situation, please confirm the latest guidance from a professional or the relevant agency.